MicroRNA 3670-3 (MIR3670-3)

MicroRNA 3670-3 (MIR3670-3) is a short (20–24 nucleotides) non-coding RNA molecule that regulates gene expression at the post-transcriptional level, primarily by binding to complementary sequences in mRNAs, leading to inhibition of translation or mRNA destabilization and degradation[1][5]. Like other microRNAs, it is transcribed as part of a primary transcript, processed by the Drosha ribonuclease in the nucleus, and further processed by Dicer ribonuclease in the cytoplasm to produce the mature microRNA, which is then loaded onto the RNA-induced silencing complex (RISC)[1][2][3]. While the general biological role of microRNAs is well characterized, there is currently no specific functional or disease association reported for MIR3670-3 itself in public databases. Key points: - MIR3670-3 is not a classical therapeutic target (such as a receptor, enzyme, transporter, etc.) but rather a regulatory RNA molecule[1][2][5]. - There is no evidence of direct drug interactions, well-established disease associations, or biomarker use for MIR3670-3 as of the current knowledge in major databases[1][5]. - The molecule is best classified within the microRNA family, under non-coding RNAs. If structured information is later required, further research or specialized reviews would be necessary to determine disease roles, interacting drugs, or clinical utility for MIR3670-3. The current entry is accurate for its molecular identity and general class, but the known literature does not provide detailed clinical or pharmacological annotations specific to this microRNA.

Other names

MIR3670-3hsa-mir-3670-3